No Definite Symptom Index for Recurrence in Head and Neck Cancer, Small Study Suggests

Share this content:
In head and neck squamous cell carcinoma, there was no definite index of symptoms to indicate recurrence or second malignancy.
In head and neck squamous cell carcinoma, there was no definite index of symptoms to indicate recurrence or second malignancy.

In patients treated for head and neck squamous cell carcinoma (HNSCC), there was no definite index of symptoms that indicated local recurrence or second primary malignancy in a small Taiwanese study published online ahead of print in Head & Neck.1

Pei-Hsuan Lin, MD, and fellow researchers from the National Taiwan University examined 136 patients with HNSCC who were diagnosed between January 2010 and June 2014, 32 of whom had local recurrence and 14 of whom had second primary malignancy.

“The purposes of this study were to identify an index of symptoms and signs of swallowing disorders that indicate the occurrence of local recurrence or second primary malignancy,” the authors noted.

RELATED: Cetuximab, Docetaxel and Cisplatin Shows Activity in Head and Neck Cancer

They found that common swallowing disorders and objective transnasal esophagoscopy findings were similar between patients with and without local recurrence or second primary malignancy.

“Routine transnasal esophagoscopy examination of patients treated for HNSCC with swallowing disorders is strongly recommended,” the authors concluded.

Reference

  1. Lin P-H, Wang C-P, Lou P-J, et al. Evaluation of swallowing disorders by use of transnasal esophagoscopy in patients treated for head and neck cancer. [published online ahead of print September 2, 2015]. Head Neck. doi: 10.1002/hed.24174.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters